Pharmacogenomic information from CPIC and DPWG guidelines and its application on drug labels DY Yoon, S Lee, MS Ban, IJ Jang, SH Lee Translational and Clinical Pharmacology 28 (4), 189, 2020 | 22 | 2020 |
Effect of meal timing on pharmacokinetics and pharmacodynamics of tegoprazan in healthy male volunteers DY Yoon, J Sunwoo, N Shin, AR Kim, B Kim, GS Song, IJ Jang, SH Lee Clinical and Translational Science 14 (3), 934-941, 2021 | 16 | 2021 |
Prediction of drug–drug interaction potential of tegoprazan using physiologically based pharmacokinetic modeling and simulation DY Yoon, SH Lee, IJ Jang, M Kim, H Lee, S Kim, B Kim, GS Song, S Rhee Pharmaceutics 13 (9), 1489, 2021 | 8 | 2021 |
Comparison of pharmacokinetics of a fixed-dose combination of amlodipine/losartan/rosuvastatin with concomitant administration of amlodipine/losartan and rosuvastatin in … DY Yoon, SI Park, JA Jung, YI Kim, IJ Jang, JY Chung Drug Design, Development and Therapy, 661-668, 2020 | 5 | 2020 |
Safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of vutiglabridin: A first‐in‐class, first‐in‐human study JY Na, DY Yoon, H Yoo, SH Lee, KS Yu, IJ Jang, SK Yoo, Y Kim, J Oh Clinical and Translational Science 15 (11), 2744-2757, 2022 | 4 | 2022 |
The necessary conduct: Exploratory multiregional clinical trials in East Asia I Jeon, YK Kim, I Song, DY Yoon, KY Huh, X Jin, KS Yu, SH Lee, ... Clinical and Translational Science 14 (6), 2399-2407, 2021 | 4 | 2021 |
Comprehensive analysis of important pharmacogenes in Koreans using the DMET™ platform B Kim, DY Yoon, SH Lee, IJ Jang, KS Yu, JY Cho, J Oh Translational and Clinical Pharmacology 29 (3), 135, 2021 | 3 | 2021 |
Comparison of the pharmacokinetics, safety, and tolerability of two empagliflozin formulations in healthy Korean subjects X Jiang, S Bae, DY Yoon, SJ Park, J Oh, JY Cho, KS Yu Drug Design, Development and Therapy, 2137-2145, 2023 | 2 | 2023 |
Comparative pharmacokinetics between two tablets of tramadol 37.5 mg/acetaminophen 325 mg and one tablet of tramadol 75 mg/acetaminophen 650 mg for extended-release fixed-dose … HC Kim, DY Yoon, SH Lee, IJ Jang, JH Hong, JW Kim Translational and Clinical Pharmacology 30 (2), 112, 2022 | 2 | 2022 |
Effects of food and race on the pharmacokinetics of lazertinib in healthy subjects and patients with EGFR mutation-positive advanced non-small cell lung cancer KY Huh, Y Lim, DY Yoon, JG Hwang, S Sim, J Kang, J Wang, M Kim, ... Lung Cancer 175, 112-120, 2023 | 1 | 2023 |
Effects of meal type on the bioavailability of vutiglabridin, a novel anti‐obesity agent, in healthy subjects H Won, DY Yoon, S Lee, JY Cho, J Oh, IJ Jang, SK Yoo, KS Yu Clinical and Translational Science 17 (3), e13744, 2024 | | 2024 |
Pharmacokinetics and Safety of Extended-release Ranolazine in Korean and White Healthy Subjects H Yoo, SW Lee, DY Yoon, SH Yoon, JY Cho, KS Yu, IJ Jang, SH Lee Clinical Therapeutics 43 (3), 526-534. e4, 2021 | | 2021 |